OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
Paul A. Meyers, Noah Federman, Najat C. Daw, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 31, pp. 3725-3734
Closed Access | Times Cited: 5
Paul A. Meyers, Noah Federman, Najat C. Daw, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 31, pp. 3725-3734
Closed Access | Times Cited: 5
Showing 5 citing articles:
Targeting the EphA2 pathway: could it be the way for bone sarcomas?
G Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
G Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma
Erdong Wei, Ana Mitanoska, Quinn O'Brien, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
Erdong Wei, Ana Mitanoska, Quinn O'Brien, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
A novel combination of CDK4/6 and PI3K inhibitors exhibits highly synergistic activity and translational potential in Ewing sarcoma.
Maria Ana Isabel C. De Los Santos, Helen F. Gloege, Min Shen, et al.
(2024)
Closed Access
Maria Ana Isabel C. De Los Santos, Helen F. Gloege, Min Shen, et al.
(2024)
Closed Access
Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma
Joseph Hsieh, Etienne Danis, Charles R. Owens, et al.
Oncogene (2024) Vol. 44, Iss. 1, pp. 19-29
Open Access
Joseph Hsieh, Etienne Danis, Charles R. Owens, et al.
Oncogene (2024) Vol. 44, Iss. 1, pp. 19-29
Open Access
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover
Ying Ma, Ruirui Wang, Jinzhuang Liao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Ying Ma, Ruirui Wang, Jinzhuang Liao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
